TMJ FOSSA-EMINENCE/CONDYLAR PROSTHESES

FDA Premarket Approval P000023

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the tmj fossa-eminence/condylar prosthesis system. The device is indicated for reconstruction of the temporomandibular joint. Patients should be considered if they have one or more of the following conditions: 1) inflammatory arthritis involving the temporomandibular joint not responsive to other modalities of treatment 2) recurrent fibrous and/or bony ankylosis not responsive to other modalities of treatment 3) failed tissue graft 4) failed alloplastic joint reconstruction 5) loss of vertical mandibular height and/or occlusal relationship due to bone resorption, trauma, developmental relationship due to bone resorption, trauma, developmental abnormality, or pathologic lesion.

DeviceTMJ FOSSA-EMINENCE/CONDYLAR PROSTHESES
Generic NameJoint, Temporomandibular, Implant
ApplicantNEXUS CMF, LLC
Date Received2000-06-20
Decision Date2001-01-05
Notice Date2001-06-11
PMAP000023
SupplementS
Product CodeLZD 
Docket Number01M-0255
Advisory CommitteeDental
Expedited ReviewNo
Combination Product No
Applicant Address NEXUS CMF, LLC 17301 West Colfax Avenue suite 170 golden, CO 80401
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P000023Original Filing
S011 2015-01-16 30-day Notice
S010 2014-05-02 30-day Notice
S009 2014-03-04 Real-time Process
S008 2012-05-03 135 Review Track For 30-day Notice
S007 2011-08-29 Normal 180 Day Track No User Fee
S006 2011-05-11 Normal 180 Day Track No User Fee
S005
S004 2002-12-26 Normal 180 Day Track
S003 2002-06-20 Normal 180 Day Track
S002 2002-06-20 Normal 180 Day Track
S001 2002-06-18 Normal 180 Day Track

© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.